ITGAE and neoplasm: In this study, we sorted tumor-reactive and bystander CD8+ TILs from treatment-naïve primary CRC patients based on the expression of CD39 and CD103, and naïve and TEM CD8+ T cells from peripheral blood based on the expression of CD45RO, CD45RA, and CCR7.